Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp-Reference-Cited by-同舟云学术

Activity of SCH 56592 compared with those of fluconazole and itraconazole against Candida spp

Published:1997-10 Issue:10 Volume:41 Page:2310-2311
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Law D¹,Moore C B¹,Denning D W¹

Affiliation:

1. Department of Microbiology, Hope Hospital, Salford, United Kingdom.

Abstract

The in vitro activity of Schering 56592, a new azole drug, was compared with those of fluconazole and itraconazole against 103 isolates of Candida comprising 10 different species. Schering 56592 was more active than itraconazole and fluconazole, and it was active against many fluconazole-resistant isolates.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.41.10.2310

Reference12 articles.

1. Fluconazole-resistant candidosis in an HIV cohort;Baily G. G.;AIDS,1994

2. Can we prevent azole resistance in fungi;Denning D. W.;Lancet,1995

3. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests;Espinel-Ingroff A.;J. Clin. Microbiol.,1992

4. In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts;Galgiani J. N.;Antimicrob. Agents Chemother.,1997

5. Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species;Johnson E. M.;J. Antimicrob. Chemother.,1995

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surfactin and Capric Acid Affect the Posaconazole Susceptibility of Candida albicans Strains with Altered Sterols and Sphingolipids Biosynthesis;International Journal of Molecular Sciences;2023-12-15

2. Recent Advances in Azole Based Scaffolds as Anticandidal Agents;Letters in Drug Design & Discovery;2019-04-15

3. Mitochondrial Complex I Is a Global Regulator of Secondary Metabolism, Virulence and Azole Sensitivity in Fungi;PLOS ONE;2016-07-20

4. Structural characterization of a novel degradant of the antifungal agent posaconazole;Journal of Pharmaceutical and Biomedical Analysis;2012-07

5. Characterization of an unusual ring-contraction degradant of the antifungal agent posaconazole;Magnetic Resonance in Chemistry;2012-06-19